Medirom Healthcare Reports June 2024 KPIs
Ticker: MRM · Form: 6-K · Filed: Jul 23, 2024 · CIK: 1819704
| Field | Detail |
|---|---|
| Company | Medirom Healthcare Technologies INC. (MRM) |
| Form Type | 6-K |
| Filed Date | Jul 23, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: kpi, operational-update, foreign-private-issuer
TL;DR
Medirom Healthcare dropped its June 2024 KPIs today, check the 6-K.
AI Summary
Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for June 2024 via a press release on July 23, 2024. The filing is a Form 6-K, which is a report of foreign private issuers.
Why It Matters
This filing provides investors with updated operational metrics for Medirom Healthcare Technologies Inc., allowing them to track the company's performance.
Risk Assessment
Risk Level: low — This is a routine filing providing operational updates, not a material event like an acquisition or significant financial distress.
Key Players & Entities
- Medirom Healthcare Technologies Inc. (company) — Filer of the report
- July 23, 2024 (date) — Date of press release and filing
- June 2024 (date) — Period for which KPIs are reported
FAQ
What type of report is this filing?
This filing is a Form 6-K, a report of a foreign private issuer.
What information is being announced in the press release?
The press release announces Medirom Healthcare Technologies Inc.'s major Key Performance Indicators (KPIs) updated for the month of June 2024.
When was the press release issued?
The press release was issued on July 23, 2024.
What is the company's principal executive office address?
The company's principal executive office is located at 2-3-1 Daiba, Minato-ku, Tokyo 135-0091, Japan.
Does the company file annual reports under Form 20-F or 40-F?
The company files annual reports under Form 20-F.
Filing Stats: 272 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-07-23 06:15:09
Filing Documents
- tmb-20240723x6k.htm (6-K) — 18KB
- tmb-20240723xex99d1.htm (EX-99.1) — 105KB
- tmb-20240723xex99d1001.jpg (GRAPHIC) — 5KB
- tmb-20240723xex99d1003.jpg (GRAPHIC) — 47KB
- tmb-20240723xex99d1004.jpg (GRAPHIC) — 56KB
- tmb-20240723xex99d1005.jpg (GRAPHIC) — 52KB
- tmb-20240723xex99d1006.jpg (GRAPHIC) — 43KB
- tmb-20240723xex99d1007.jpg (GRAPHIC) — 50KB
- tmb-20240723xex99d1008.jpg (GRAPHIC) — 52KB
- tmb-20240723xex99d1009.jpg (GRAPHIC) — 48KB
- 0001558370-24-009954.txt ( ) — 611KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: July 23, 2024 MEDIROM HEALTHCARE TECHNOLOGIES INC. By: /s/ Fumitoshi Fujiwara Name: Fumitoshi Fujiwara Title: Chief Financial Officer